AGIO CCO logs grants, RSU vesting and tax sales
AGIOS PHARMACEUTICALS, INC.
Rhea-AI Filing Summary
AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Tsveta Milanova reported a mix of equity grants, vesting, and tax-related share sales. On March 1, 2026, she received 14,000 restricted stock units and 52,000 stock options, with both awards vesting over multiple years starting March 1, 2027.
On March 2, 2026, previously granted restricted stock units vested, converting into 5,666 and 4,000 shares of common stock at no cost through derivative exercises. To cover tax withholding from these vestings, she sold 2,868 shares of common stock in open-market transactions at $28.96 per share under durable automatic Rule 10b5-1 instructions. After these trades, she continued to hold tens of thousands of shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
8 txns
Insider
Milanova Tsveta
Role
Chief Commercial Officer
Sold
2,868 shs ($83K)
Approx. gross sale proceeds
$83K
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted stock units | 5,666 | $0.00 | $0.00 |
| Exercise | Restricted stock units | 4,000 | $0.00 | $0.00 |
| Exercise | Common stock | 5,666 | $0.00 | $0.00 |
| Sale | Common stock | 1,681 | $28.96 | $49K |
| Exercise | Common stock | 4,000 | $0.00 | $0.00 |
| Sale | Common stock | 1,187 | $28.96 | $34K |
| Grant/Award | Restricted stock units | 14,000 | $0.00 | $0.00 |
| Grant/Award | Stock options (right to buy) | 52,000 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted stock units — 27,667 contracts (Direct);
Stock options (right to buy) — 52,000 contracts (Direct);
Common stock — 41,591 shares (Direct)
Footnotes (7)
- F1. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.
- F2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025.
- F3. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F4. The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments.
- F5. This option was granted on March 1, 2026. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter.
- F6. The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.
- F7. The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did AGIO Chief Commercial Officer Tsveta Milanova report in this Form 4?
She reported new equity awards, RSU vesting, and related tax sales. Milanova received 14,000 restricted stock units and 52,000 stock options, plus converted vested RSUs into common shares and sold 2,868 shares at $28.96 to cover tax withholding.
Were Tsveta Milanova’s AGIO stock sales discretionary or pre-arranged?
The sales were pre-arranged under durable automatic instructions. Footnotes explain they were executed pursuant to Rule 10b5-1(c) instructions embedded in her restricted stock unit agreements, solely to satisfy tax withholding obligations from RSU vesting.
What new restricted stock units did AGIO grant to Tsveta Milanova?
She was granted 14,000 restricted stock units on March 1, 2026. Each unit represents a contingent right to one AGIOS PHARMACEUTICALS common share, vesting in three equal annual installments beginning March 1, 2027, subject to the stated vesting schedule.
What are the terms of the new AGIO stock options granted to Tsveta Milanova?
She received stock options covering 52,000 shares on March 1, 2026. Twenty‑five percent of the underlying shares vest on March 1, 2027, with the remaining 75% vesting in 36 equal monthly installments afterward, according to the disclosed vesting schedule.
AI-generated analysis. How Rhea-AI works. Not financial advice.
